Q&A

Sustainability Goals Impacting Biopharma

GettyImages-1271641693 Sustainability

Stacey Treichler, Senior Director of Strategy & Marketing at Purolite, discusses trends in the pharmaceutical industry, with a focus on monoclonal antibodies and advanced therapies driving innovation in disease treatment. Manufacturing challenges arise with complex therapies, and Purolite has developed products, such as Praesto™ CH1 and Praesto™ HipH, to address them. Treichler emphasizes the importance of sustainability in the industry, encouraging companies to consider their suppliers' operations as part of their environmental footprint. She also suggests that water usage is key to reducing energy consumption and greenhouse gas emissions. Treichler believes value is created when companies consider business impact, operational impact, and environmental impact together. Learn more about the sustainability trend in the pharmaceutical industry and how it is influencing business practices.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online